1. Home
  2. VLY vs SYRE Comparison

VLY vs SYRE Comparison

Compare VLY & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valley National Bancorp

VLY

Valley National Bancorp

HOLD

Current Price

$14.41

Market Cap

7.6B

Sector

Finance

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$83.43

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VLY
SYRE
Founded
1927
2013
Country
United States
United States
Employees
3675
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
6.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
VLY
SYRE
Price
$14.41
$83.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
12
Target Price
$14.65
$85.08
AVG Volume (30 Days)
5.8M
886.6K
Earning Date
04-23-2026
05-08-2026
Dividend Yield
3.31%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.58
N/A
Revenue Next Year
$8.51
N/A
P/E Ratio
$13.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.36
$13.93
52 Week High
$14.70
$84.43

Technical Indicators

Market Signals
Indicator
VLY
SYRE
Relative Strength Index (RSI) 64.69 64.66
Support Level $13.30 $66.78
Resistance Level N/A N/A
Average True Range (ATR) 0.29 4.35
MACD 0.08 0.68
Stochastic Oscillator 76.87 91.85

Price Performance

Historical Comparison
VLY
SYRE

About VLY Valley National Bancorp

Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: